APLP1 as a cerebrospinal fluid biomarker for γ-secretase modulator treatment

APLP1 as a cerebrospinal fluid biomarker for γ-secretase modulator treatment

Bibliographic Details
Main Authors:	Sjödin, Simon, Andersson, Kerstin K. A., Mercken, Marc, Zetterberg, Henrik, Borghys, Herman, Blennow, Kaj, Portelius, Erik
Format:	Online
Language:	English
Published:	BioMed Central 2015
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4687145/

Similar Items

A single dose of the γ-secretase inhibitor semagacestat alters the cerebrospinal fluid peptidome in humans
by: Hölttä, Mikko, et al.
Published: (2016)

Cerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer's disease
by: Mattsson, Niklas, et al.
Published: (2016)

Longitudinal Measurements of Cerebrospinal Fluid Biomarkers in Parkinson's Disease
by: Hall, Sara, et al.
Published: (2016)

Longitudinal cerebrospinal fluid biomarker measurements in preclinical sporadic Alzheimer's disease: A prospective 9-year study
by: Stomrud, Erik, et al.
Published: (2015)

BACE1 Inhibition Induces a Specific Cerebrospinal Fluid β-Amyloid Pattern That Identifies Drug Effects in the Central Nervous System
by: Mattsson, Niklas, et al.
Published: (2012)

Cerebrospinal fluid biomarkers for Alzheimer disease and subcortical axonal damage in 5,542 clinical samples
by: Skillbäck, Tobias, et al.
Published: (2013)

Cerebrospinal fluid neurogranin and YKL‐40 as biomarkers of Alzheimer's disease
by: Janelidze, Shorena, et al.
Published: (2015)

Targeting LAMP2 in human cerebrospinal fluid with a combination of immunopurification and high resolution parallel reaction monitoring mass spectrometry
by: Sjödin, Simon, et al.
Published: (2016)

Evaluating Amyloid-β Oligomers in Cerebrospinal Fluid as a Biomarker for Alzheimer’s Disease
by: Hölttä, Mikko, et al.
Published: (2013)

Neuronal and Glia-Related Biomarkers in Cerebrospinal Fluid of Patients with Acute Ischemic Stroke
by: Hjalmarsson, Clara, et al.
Published: (2014)

Peptidome Analysis of Cerebrospinal Fluid by LC-MALDI MS
by: Hölttä, Mikko, et al.
Published: (2012)

Fluid biomarkers in Alzheimer’s disease – current concepts
by: Rosén, Christoffer, et al.
Published: (2013)

Cognitive Performance and Cerebrospinal Fluid Biomarkers of Neurodegeneration: A Study of Patients with Bipolar Disorder and Healthy Controls
by: Rolstad, Sindre, et al.
Published: (2015)

Cerebrospinal fluid CXCL13 in Lyme neuroborreliosis and asymptomatic HIV infection
by: Bremell, Daniel, et al.
Published: (2013)

Effects of cerebrovascular disease on amyloid precursor protein metabolites in cerebrospinal fluid
by: Rosengren Lars, et al.
Published: (2010-07-01)

Alzheimer-associated cerebrospinal fluid fragments of neurogranin are generated by Calpain-1 and prolyl endopeptidase
by: Bruno Becker, et al.
Published: (2018-08-01)

The past and the future of Alzheimer's disease CSF biomarkers—a journey toward validated biochemical tests covering the whole spectrum of molecular events
by: Blennow, Kaj, et al.
Published: (2015)

γ-Secretase Modulators: Can We Combine Potency with Safety?
by: Gijsen, Harrie J. M., et al.
Published: (2012)

Increased Levels of Chitotriosidase and YKL-40 in Cerebrospinal Fluid from Patients with Alzheimer's Disease
by: Rosén, Christoffer, et al.
Published: (2014)

Changes in serum and cerebrospinal fluid cytokines in response to non-neurological surgery: an observational study
by: Bromander, Sara, et al.
Published: (2012)

Cerebrospinal fluid biomarkers in parkinsonian conditions: an update and future directions
by: Magdalinou, Nadia, et al.
Published: (2014)

Agitation in Dementia: Relation to Core Cerebrospinal Fluid Biomarker Levels
by: Bloniecki, Victor, et al.
Published: (2014)

The influence of insulin resistance on cerebrospinal fluid and plasma biomarkers of Alzheimer’s pathology
by: Sarah Westwood, et al.
Published: (2017-04-01)

The relationship between cerebrospinal fluid tau markers, hippocampal volume, and delayed primacy performance in cognitively intact elderly individuals
by: Bruno, Davide, et al.
Published: (2015)

Increased Cerebrospinal Fluid Levels of Ubiquitin Carboxyl-Terminal Hydrolase L1 in Patients with Alzheimer's Disease
by: Öhrfelt, Annika, et al.
Published: (2016)

Normalisation of cerebrospinal fluid biomarkers parallels improvement of neurological symptoms following HAART in HIV dementia – case report
by: Andersson, Lars-Magnus, et al.
Published: (2006)

SNAP-25 is a promising novel cerebrospinal fluid biomarker for synapse degeneration in Alzheimer’s disease
by: Brinkmalm, Ann, et al.
Published: (2014)

Update on ultrasensitive technologies to facilitate research on blood biomarkers for central nervous system disorders
by: Andreasson, Ulf, et al.
Published: (2016)

Multiple γ-secretase product peptides are coordinately increased in concentration in the cerebrospinal fluid of a subpopulation of sporadic Alzheimer’s disease subjects
by: Hata, Saori, et al.
Published: (2012)

The γ-Secretase Modulator, BMS-932481, Modulates Aβ Peptides in the Plasma and Cerebrospinal Fluid of Healthy Volunteers
by: Soares, Holly D., et al.
Published: (2016)

Characterization of the postsynaptic protein neurogranin in paired cerebrospinal fluid and plasma samples from Alzheimer’s disease patients and healthy controls
by: Kvartsberg, Hlin, et al.
Published: (2015)

Neurogranin and tau in cerebrospinal fluid and plasma of patients with acute ischemic stroke
by: Ann De Vos, et al.
Published: (2017-08-01)

Increased cerebrospinal fluid soluble TREM2 concentration in Alzheimer’s disease
by: Heslegrave, Amanda, et al.
Published: (2016)

Glial and neuronal markers in cerebrospinal fluid predict progression in multiple sclerosis
by: Martínez, M Alba Mañé, et al.
Published: (2015)

The cerebrospinal fluid biomarker profile in an HIV-infected subject with Alzheimer’s disease
by: Mäkitalo, Signar, et al.
Published: (2015)

Cerebrospinal Fluid Levels of sAPPα and sAPPβ in Lewy Body and Alzheimer's Disease: Clinical and Neurochemical Correlates
by: Mulugeta, Ezra, et al.
Published: (2011)

Cerebrospinal Fluid Inflammatory Biomarkers Reflect Clinical Severity in Huntington’s Disease
by: Rodrigues, Filipe Brogueira, et al.
Published: (2016)

Cerebrospinal fluid biomarkers in Alzheimer's disease: Diagnostic accuracy and prediction of dementia
by: Forlenza, Orestes V., et al.
Published: (2015)

Cerebrospinal Fluid (CSF) 25-Hydroxyvitamin D Concentration and CSF Acetylcholinesterase Activity Are Reduced in Patients with Alzheimer's Disease
by: Johansson, Per, et al.
Published: (2013)

Cerebrospinal fluid (CSF) 25-hydroxyvitamin D concentration and CSF acetylcholinesterase activity are reduced in patients with Alzheimer's disease.
by: Per Johansson, et al.